Pharsight

Loreal Usa patents expiration

1. Anthelios Sx patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5587150 LOREAL USA Photostable cosmetic screening composition containing a UV-A screening agent and an alkyl β, β-diphenylacrylate or α-cyano-β,β-diphenylacrylate
Dec, 2013

(10 years ago)

Drugs and Companies using AVOBENZONE; ECAMSULE; OCTOCRYLENE ingredient

Market Authorisation Date: 21 July, 2006

Treatment: Sunscreen

Dosage: CREAM;TOPICAL

More Information on Dosage

ANTHELIOS SX family patents

Family Patents